| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 100905-32-6 | 4,5-Dimethoxy-2-nitrobenzoic acid phenyl ester | C15H13NO6 |
| 100905-33-7 | Ethyl 4,5-dimethoxy-2-nitrobenzoate | C11H13NO6 |
| 100905-89-3 | Panamycin 607 | C35H61NO7 |
| 100908-60-9 | alpha-Acetamido-N-Isobutyl-beta-Phenylacrylamide | C15H20N2O2 |
| 100908-61-0 | N-Allyl-alpha-Methylcinnamamide | C13H15NO |
| 100908-62-1 | 2-Cyano-3-(M-Fluorophenyl)Acrylamide | C10H7FN2O |
| 100908-63-2 | N-Cyclopropyl-alpha-Methyl-M-Trifluoromethylcinnamamide | C14H14F3NO |
| 100908-65-4 | N-(2-(Diethylamino)ethyl)-N-(4-pyridylmethyl)cinnamamide dihydrochloride | C21H29Cl2N3O |
| 100908-67-6 | 2-Methyl-3-(3-(Trifluoromethyl)Phenyl)-2-Propenamide | C11H10F3NO |
| 100908-68-7 | 3-Phenyl-N-1-Piperidinyl-2-Propenamide | C14H18N2O |
| 100908-72-3 | 4-Chloro-alpha-Phenyl-Cinnamic Acid 3-Tropanyl Ester Hydrochloride Hydrate | C23H25Cl2NO2 |
| 100908-77-8 | 2-Chloro-alpha-Nitrocinnamonitrile | C9H5ClN2O2 |
| 100910-66-5 | 5-Methylpyridine-3-carboxaldehyde | C7H7NO |
| 100910-69-8 | 2-Methyl-2-Propanyl 3-Pyrrolidinylacetate | C10H19NO2 |
| 100910-77-8 | 3,6-Dimethyl-1,2,4-Benzenetriamine | C8H13N3 |
| 100911-07-7 | N-Methyl-1,4,5,6-Tetrahydro-3-Pyridinecarboxamide | C7H12N2O |
| 100911-22-6 | N-Methyl-2-(1H-Pyrrol-1-Yl)Ethanamine | C7H12N2 |
| 100911-26-0 | 4-Isopropyl-3,4-Dihydro-2H-Pyrrole-2-Carboxylic Acid | C8H13NO2 |
| 100911-27-1 | 4-Isopropyl-2,5-Dihydro-1H-Pyrrole-2-Carboxylic Acid | C8H13NO2 |
| 100911-43-1 | 4,5,5-Trimethyl-2-Oxo-1,3-Oxazolidine-4-Carboxylic Acid | C7H11NO4 |
| 100911-51-1 | 6-Hydroxyheptanehydrazide | C7H16N2O2 |
| 100912-15-0 | 3-Methyl-1-Tridecyn-3-Ol | C14H26O |
| 100914-20-3 | 6,8-Dichloro-2-Phenyl-4H-Chromen-4-One | C15H8Cl2O2 |
| 100914-36-1 | 3',6-Dinitroflavone | C15H8N2O6 |
| 100914-76-9 | 4,6-Dichloro-2-Phenylquinoline | C15H9Cl2N |
| 100915-92-2 | Tyr-Corticotropin Releasing Factor Human, Rat | |
| 100916-78-7 | Diethyl(2-Hydroxyethyl)Methylammonium Bromide alpha-Cyclohexyl-1-Hydroxycyclohexane acetate | C21H40BrNO3 |
| 100921-72-0 | 2-Furyl Pivalate | C9H12O3 |
| 100924-68-3 | 2-((2-Dimethylaminobenzyl)Sulfinyl)Benzimidazole | C16H17N3OS |
| 100927-09-1 | N-[(1R)-1-Cyanoethyl]carbamic acid tert-butyl ester | C8H14N2O2 |
| 100927-10-4 | N-[(1R)-2-Amino-1-methylethyl]carbamic acid tert-butyl ester | C8H18N2O2 |
| 100927-13-7 | Idaverine | C24H39N3O3 |
| 100927-14-8 | Befiperide | C25H31N3O2 |
| 100927-97-7 | 2-Naphthoxyacetic Acid Ethylene Monoamide | C14H16N2O2 |
| 100928-03-8 | (betaS,1R,3aR,4S,7aR)-4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]octahydro-beta,7a-dimethyl-1H-indene-1-ethanol | C19H38O2Si |
| 100928-04-9 | (2S)-2-[(4S,7aR)-4-{[Dimethyl(2-Methyl-2-Propanyl)Silyl]Oxy}-7A-Methyloctahydro-1H-Inden-1-Yl]Propyl 4-Methylbenzenesulfonate | C26H44O4SSi |
| 100929-45-1 | Sodium 4-{[(2,4-Diamino-6-Pteridinyl)Methyl]Amino}Benzoate | C14H12N7NaO2 |
| 100929-47-3 | Doxycycline Hydrochloride | C22H25ClN2O8 |
| 100929-48-4 | 2-Amino-1,3-Propanediol Hydrochloride (1:1) | C3H10ClNO2 |
| 100929-50-8 | [D-Ala2]Met-Enkephalin Amide | |
| 100929-51-9 | 3-[(2-Methylphenyl)Carbamoyl]-2-Anthryl Dihydrogen Phosphate - Sodium (1:1) | C22H18NNaO5P |
| 100929-52-0 | 11-D-Tryptophan-13-L-isoleucine-neurotensin (ox) | C80H122N22O19 |
| 100929-53-1 | L-Tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-Nalpha-methyl-L-phenylalaninamide monoacetate (salt) | C28H39N5O8 |
| 100929-57-5 | Glycylglycyl-L-Phenylalanyl-L-Leucinamide Acetate (1:1) | C21H33N5O6 |
| 100929-59-7 | Glycylglycyl-L-Phenylalanyl-L-Methioninamide Acetate (1:1) | C20H31N5O6S |
| 100929-62-2 | L-Tyrosyl-D-Alanylglycyl-L-Phenylalanyl-L-Methionine Monoacetate (Salt) | C30H43N5O10S |
| 100929-67-7 | Met-Enkephalin Amide | C29H40N6O8S |
| 100929-71-3 | Codehydrase II, reduced, compd. with cyclohexanamine (1:4) | C21H30N7O17P3.4(C6H13N) |
| 100929-77-9 | Nicotinamide adenine dinucleotide 2:3-cyclic monophosphate disodium salt hydrate | |
| 100929-80-4 | N-Formyl-L-alanylglycyl-L-seryl-L-glutamic acid | C14H22N4O9 |